Company intelligence
Fecundis Lab
Advancing assisted reproduction through sperm capacitation science | HyperSperm
About Fecundis Lab
Fecundis Lab is a reproductive biotechnology company focused on assisted reproduction. We are the team behind HyperSperm, the first sperm capacitation kit developed to address a critical and long-overlooked biological step in IVF workflows. Our work combines reproductive biology, translational science, and product development to turn cutting-edge science into practical innovation for fertility care. By focusing on sperm capacitation, we are advancing an area with major clinical relevance but limited product innovation to date. We are committed to developing science-driven solutions that improve the consistency, efficiency, and overall performance of ART.
Verified activity
Signals from Fecundis Lab
5 published signals
Presence & Recognition
Fecundis Lab is represented by Guillermina María Luque at the SAMeR 2026 conference in Buenos Aires.
Reported by Fecundis Lab
Presence & Recognition
Fecundis Lab participated in the Santa Fe Business Forum 2026 in Rosario, representing the company with Co-Founder Dario Krapf and Business Development & Product Development Lead Carolina Baro Graf.
Reported by Fecundis Lab
Presence & Recognition
Fecundis Lab participated in the Córdoba International Biotechnology Congress in Córdoba, Argentina, on 10–11 September.
Reported by Fecundis Lab
Presence & Recognition
Fecundis Lab participated in the SAU 2026 conference in Buenos Aires to discuss the optimization of sperm quality during in vitro fertilization treatments.
Reported by Fecundis Lab
Presence & Recognition
Fecundis Lab co-founder and co-CSO Dario Krapf is attending the Santa Fe Business Forum 2026 in Rosario, Argentina, from Aug 31 to Sept 3.
Reported by Fecundis Lab